Skip to main content

Table 2 A multivariate logistic regression analysis for predicting initial IVIG resistance in KD

From: Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study

Model 1 β SE Walds P value OR 95% CI Points
 Age ≥ 48 months 0.000 0.006 0.001 0.976 1.000 0.989–1.011  
 Cervical lymphadenopathy −0.245 0.272 0.815 0.367 0.782 0.459–1.333  
 NLR ≥ 2.91 0.584 0.354 2.720 0.099 1.794 0.896–3.592  
 PLR ≥ 134 0.260 0.303 0.736 0.391 1.297 0.716–2.351  
 CAR≥2.07 0.762 0.321 5.629 0.018 2.142 1.142–4.019 5.0
 TBil≥9.5 μmol/L 0.566 0.282 4.040 0.044 1.761 1.014–3.058 3.5
 Na+ ≤ 135.7 mmol/L −0.729 0.270 7.322 0.007 0.482 0.284–0.818 4.5
 Intercept 1.214 0.425 8.174 0.004 3.366  
Model 2
 Age ≥ 48 months 0.425 0.317 1.793 0.181 1.529 0.821–2.848  
 Cervical lymphadenopathy −0.237 0.272 0.758 0.384 0.789 0.463–1.345  
 NLR ≥ 2.91 0.452 0.354 1.628 0.202 1.571 0.785–3.146  
 PLR ≥ 134 0.249 0.305 0.669 0.413 1.283 0.706–2.331  
 CRP ≥ 57.7 mg/L 0.567 0.324 3.062 0.080 1.762 0.934–3.325  
 ALB≤34.1 g/L −0.698 0.276 6.398 0.011 0.497 0.290–0.855 5.0
 TBil≥9.5 μmol/L 0.589 0.287 4.227 0.040 1.803 1.028–3.162 4.0
 Na+ ≤ 135.7 mmol/L −0.670 0.274 6.007 0.014 0.512 0.299–0.874 4.5
 Intercept 1.160 0.441 6.931 0.008 3.191  
  1. Abbreviations: ALB Albumin; CRP C-reactive protein; CAR C-reactive protein-to-albumin ratio; IVIG Intravenous immunoglobulin; KD Kawasaki disease; NLR Neutrophil-lymphocyte ratio; Na+ Sodium; PLR Platelet-lymphocyte ratio; TBil Total bilirubin;